The TOMAHAWK Study

September 16, 2021 00:29:18
The TOMAHAWK Study
Critical Care Perspectives in Emergency Medicine
The TOMAHAWK Study

Sep 16 2021 | 00:29:18

/

Show Notes

The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate or delayed coronary angiography.  However, the COACT Trial included only OHCA with a shockable rhythm and overall had a very low number of patients that had an acute thrombus at the time of angiography.  In this podcast, we discuss the recently published TOMAHAWK study that evaluated OHCA patients due to either a shockable or nonshockable rhythm and had no evidence of a STEMI.  Should this study change our post-arrest management of OHCA patients with a non-diagnostic ECG?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode 0

February 05, 2019 00:30:53
Episode Cover

ED Sepsis Screening - Is qSOFA Really Better?

As EDs across the country strive to meet sepsis benchmark metrics, many have implemented a variety of screening tools. With the publication of Sepsis-3,...

Listen

Episode

June 07, 2024 00:22:24
Episode Cover

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at...

Listen

Episode 0

June 15, 2023 00:30:21
Episode Cover

Do Etomidate and Propofol Increase Mortality in the Critically Ill?

Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased...

Listen